Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ · Healthcare
Lexicon Pharmaceuticals, Inc. Net Income 2009–2025
Lexicon Pharmaceuticals, Inc. annual/quarterly net income history and growth rate from 2009 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Lexicon Pharmaceuticals, Inc. net income for the quarter ending March 31, 2026 was -1.0 M, a 95.88% decrease year-over-year.
- Lexicon Pharmaceuticals, Inc. net income for the twelve months ending March 31, 2026 was -35.9 M, a 83.49% decrease year-over-year.
- Lexicon Pharmaceuticals, Inc. annual net income for 2025 was -50.3 M, a 74.88% decrease from 2024.
- Lexicon Pharmaceuticals, Inc. annual net income for 2024 was -200.4 M, a 13.15% increase from 2023.
- Lexicon Pharmaceuticals, Inc. annual net income for 2023 was -177.1 M, a 73.74% increase from 2022.
- Lexicon Pharmaceuticals, Inc. annual net income for 2022 was -101.9 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Lexicon Pharmaceuticals, Inc. Net Income — FAQ
Lexicon Pharmaceuticals, Inc. (LXRX) net income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Lexicon Pharmaceuticals, Inc.'s net income?
Lexicon Pharmaceuticals, Inc. (LXRX) reported net income of -$50M for fiscal 2025.
Where can I see LXRX's net income history?
The chart and table above show Lexicon Pharmaceuticals, Inc.'s net income by year and by quarter, including the growth rate.